WO2009112954A3 - Processes for the preparation of bosentan and related compounds - Google Patents
Processes for the preparation of bosentan and related compounds Download PDFInfo
- Publication number
- WO2009112954A3 WO2009112954A3 PCT/IB2009/005454 IB2009005454W WO2009112954A3 WO 2009112954 A3 WO2009112954 A3 WO 2009112954A3 IB 2009005454 W IB2009005454 W IB 2009005454W WO 2009112954 A3 WO2009112954 A3 WO 2009112954A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- bosentan
- preparation
- processes
- related compounds
- novel
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Abstract
Provided herein are novel, commercially viable and industrially advantageous processes for the preparation of substantially pure ethylene glycol sulfonamide compounds such as bosentan.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP09718766A EP2268634A2 (en) | 2008-03-13 | 2009-03-12 | Processes for the preparation of bosentan and related compounds using novel intermediates |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN628/CHE/2008 | 2008-03-13 | ||
| IN628CH2008 | 2008-03-13 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| WO2009112954A2 WO2009112954A2 (en) | 2009-09-17 |
| WO2009112954A3 true WO2009112954A3 (en) | 2009-11-05 |
Family
ID=40933188
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/IB2009/005454 Ceased WO2009112954A2 (en) | 2008-03-13 | 2009-03-12 | Processes for the preparation of bosentan and related compounds using novel intermediates |
Country Status (2)
| Country | Link |
|---|---|
| EP (1) | EP2268634A2 (en) |
| WO (1) | WO2009112954A2 (en) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2008272685B2 (en) | 2007-06-29 | 2013-04-18 | Generics [Uk] Limited | Process for introduction of hydroxyethoxy side chain in bosentan |
| AU2008315757A1 (en) | 2007-10-24 | 2009-04-30 | Generics [Uk] Limited | Novel crystalline forms |
| US8785461B2 (en) | 2008-02-08 | 2014-07-22 | Generics [Uk] Limited | Process for preparing bosentan |
| WO2010015623A1 (en) * | 2008-08-05 | 2010-02-11 | Farmaprojects, S. A. | Process for the preparation of endothelin receptor antagonists |
| EP2350028A1 (en) | 2008-11-03 | 2011-08-03 | Generics [UK] Limited | Hplc method for the analysis of bosentan and related substances and use of these substances as reference standards and markers |
| WO2010118992A1 (en) | 2009-04-13 | 2010-10-21 | Sandoz Ag | Process for preparation of endothelial receptor antagonist (bosentan) |
| US9139537B2 (en) | 2010-08-11 | 2015-09-22 | Megafine Pharma(P) Ltd. | Process for preparation of bosentan |
| US20130245259A1 (en) | 2012-03-16 | 2013-09-19 | Natco Pharma Limited | Process for the preparation of bosentan monohydrate |
| ES2608004T3 (en) * | 2012-12-03 | 2017-04-05 | WÖRWAG PHARMA GmbH & Co. KG | Method by phase transfer catalysis |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0743307A1 (en) * | 1995-05-16 | 1996-11-20 | Tanabe Seiyaku Co., Ltd. | Sulfonamide derivative and process for preparing the same |
| US6136971A (en) * | 1998-07-17 | 2000-10-24 | Roche Colorado Corporation | Preparation of sulfonamides |
| WO2009004374A1 (en) * | 2007-06-29 | 2009-01-08 | Generics [Uk] Limited | Process for introduction of hydroxyethoxy side chain in bosentan |
| EP2072503A2 (en) * | 2007-12-18 | 2009-06-24 | Dipharma Francis S.r.l. | Process for the preparation of bosentan |
-
2009
- 2009-03-12 WO PCT/IB2009/005454 patent/WO2009112954A2/en not_active Ceased
- 2009-03-12 EP EP09718766A patent/EP2268634A2/en not_active Withdrawn
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0743307A1 (en) * | 1995-05-16 | 1996-11-20 | Tanabe Seiyaku Co., Ltd. | Sulfonamide derivative and process for preparing the same |
| US6136971A (en) * | 1998-07-17 | 2000-10-24 | Roche Colorado Corporation | Preparation of sulfonamides |
| WO2009004374A1 (en) * | 2007-06-29 | 2009-01-08 | Generics [Uk] Limited | Process for introduction of hydroxyethoxy side chain in bosentan |
| EP2072503A2 (en) * | 2007-12-18 | 2009-06-24 | Dipharma Francis S.r.l. | Process for the preparation of bosentan |
Non-Patent Citations (3)
| Title |
|---|
| HARRINGTON, PETER J. ET AL: "Research and Development of a Second-Generation Process for Bosentan, an Endothelin Receptor Antagonist", ORGANIC PROCESS RESEARCH & DEVELOPMENT , 6(2), 120-124 CODEN: OPRDFK; ISSN: 1083-6160, 2002, XP002495602 * |
| HOPFGARTNER, G. ET AL: "Fragmentation of Bosentan (Ro 47-0203) in ion-spray mass spectrometry after collision-induced dissociation at low energy: a case of radical fragmentation of an even-electron ion", JOURNAL OF MASS SPECTROMETRY , 31(1), 69-76 CODEN: JMSPFJ; ISSN: 1076-5174, 1996, XP002483149 * |
| YANG, NING ET AL: "Synthesis of bosentan as an endothelin receptor antagonist", ZHONGGUO YAOWU HUAXUE ZAZHI , 15(4), 230-233 CODEN: ZYHZEF; ISSN: 1005-0108, 2005, XP008096375 * |
Also Published As
| Publication number | Publication date |
|---|---|
| EP2268634A2 (en) | 2011-01-05 |
| WO2009112954A2 (en) | 2009-09-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2009112954A3 (en) | Processes for the preparation of bosentan and related compounds | |
| WO2010063700A8 (en) | Novel pyrazole-4 -n-alkoxycarboxamides as microbiocides | |
| WO2011146604A3 (en) | Optical brighteners and compositions comprising the same | |
| WO2011138281A3 (en) | Process for the preparation of dithiine tetracarboxydiimides | |
| WO2011088027A8 (en) | Compounds and methods | |
| WO2011019986A3 (en) | Processes for preparing pemetrexed | |
| CA2830549C (en) | Methods and compositions for preparing noribogaine from voacangine | |
| WO2010077740A3 (en) | Novel antiviral compounds, compositions, and methods of use | |
| WO2009024342A3 (en) | Novel microbiocides | |
| WO2010111436A3 (en) | Antiviral compounds and uses thereof | |
| WO2009019015A8 (en) | Novel herbicides | |
| WO2009157019A3 (en) | Process for preparing ezetimibe using novel allyl intermediates | |
| WO2011008570A3 (en) | Sulfonate surfactants and methods of preparation and use | |
| MY161132A (en) | Novel herbicides | |
| UA102289C2 (en) | Herbicides obtained of cyclopentadione | |
| WO2012025944A3 (en) | Sitagliptin, salts and polymorphs thereof | |
| WO2008151828A3 (en) | Novel microbiocides | |
| MX2011007932A (en) | Novel herbicides. | |
| WO2010103362A3 (en) | Process for the preparation of bosentan | |
| WO2010076810A3 (en) | A process for the preparation of gefitinib | |
| WO2009127718A3 (en) | Novel microbiocides | |
| WO2009124962A3 (en) | Sulfonamides | |
| WO2009053446A3 (en) | Pregabalin intermediates and process for preparing them and pregabalin | |
| WO2008075205A3 (en) | Improved process for the preparation of voriconazole | |
| WO2009000533A8 (en) | Novel herbicides |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 09718766 Country of ref document: EP Kind code of ref document: A2 |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 2009718766 Country of ref document: EP |